Dr Kerri Beckmann

Senior Research Fellow UniSA Allied Health & Human Performance

City West Campus (08.301)
tel +61 8 830 27018

email Kerri.Beckmann@unisa.edu.au

Research Degree Supervisor

About me

Dr Kerri Beckmann is a cancer epidemiologist with an interest in the early detection and treatment of breast, prostate and colorectal cancer. She completed her PhD at the University of Adelaide, Australia in 2014. She is employed at the University of South Australia as a Research Fellow in the Cancer Epidemiology and Population Health Research Unit.

Kerri is the recipient of a Sydney Sax NHMRC Early Career Fellowship and is currently a Visiting Research Fellow at Kings College London working with the Translational Oncology and Urology Research Team.

Much of her current work is predominantly in the area of prostate cancer outcomes research. She has had a longstanding association with the South Australian Prostate Cancer... Read more

UniSA Allied Health & Human Performance

Focused on shaping community wellbeing, UniSA Allied Health & Human Performance educates future health professionals and delivers solutions-based research that addresses global health needs.

Tweets by @UniversitySA

Orcid
Scopus

Research

Highlights

In work recently published in European Urology, Kerri and her co-authors compared the risk of additional comorbidities for men with advanced prostate cancer on two different types of hormone therapy. This publication is now available online:

Beckmann K, Garmo H, Adolfsson J, Bosco C, Johansson E, Robinson D, Holmberg L, Stattin P, Van Hemelrijck M. Androgen Deprivation Therapies and Changes in Comorbidity: A comparison of gonadotropin-releasing hormone agonists and antiandrogen monotherapy as primary therapy in men with high-risk prostate cancer. European Urology. 2018 doi: 10.1016/j.eururo.2018.11.022. [Epub ahead of print].

Currently her research exploring whether older men with prostate cancer might benefit from... Read more

Research

Outputs

Research outputs for the last seven years are shown below. To see earlier years visit ORCID or Scopus

Open access indicates that an output is open access.

Highlights

Year	Output
2018	Beckmann, K, O'Callaghan, M, Vincent, A, Roder, D, Millar, J, Evans, S, McNeil, J & Moretti, K 2018, 'Australian validation of the Cancer of the Prostate Risk Assessment Post-Surgical score to predict biochemical recurrence after radical prostatectomy', ANZ Journal of Surgery, vol. 88 x 1445-1433, no. 3, pp. E183-E188. 2 2 1
2018	Lu, TC, Moretti, K, Beckmann, K, Cohen, P & O'Callaghan, M 2018, 'ISUP Group 4: a homogenous group of prostate cancers?', Pathology and Oncology Research, vol. 24, no. 2, pp. 921-925. 6 7
2018	Russell, B, Garmo, H, Beckmann, K, Stettin, P, Adolfsson, J & Van Hemelrijck, M 2018, 'A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0', PLoS One, vol. 13, no. 4, article no. e0195690, pp. 1-10. Open access 5 4
2018	Tabar, L, Chen, THH, Yen, AMF, Chen, SLS, Fann, JCY, Chiu, SYH, Ku, MM, Wu, WYY, Hsu, CY, Chen, YY, Beckmann, K, Smith, RA & Duffy, SW 2018, 'Effect of mammography screening on mortality by histological grade', Cancer Epidemiology, Biomarkers and Prevention, vol. 27, no. 2, pp. 154-157. Open access 24 21 20
2017	Beckmann, K, Vincent, A, O'Callaghan, M, Cohen, P, Chang, S, Borg, M, Evans, S, Roder, D & Moretti, K 2017, 'Oncological outcomes in an Australian cohort according to the new prostate cancer grading groupings', BMC Cancer, vol. 17, no. 1, article no. 537, pp. 1-10. Open access 2 2 1

Journal Articles

Year	Output
2023	Tiruye, T, O'Callaghan, M, Ettridge, K, Jay, A, Santoro, K, Moretti, K & Beckmann, K 2023, 'Factors impacting on sexual function among men on active surveillance for prostate cancer', Prostate, online, pp. 1-10. Open access
2023	Westerberg, M, Beckmann, K, Gedeborg, R, Irenaeus, S, Holmberg, L, Garmo, H & Stattin, P 2023, 'Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence', Journal of Clinical Epidemiology, vol. 155, pp.22-30. Open access
2022	Beckmann, K, Cahill, D, Brown, C, Van Hemelrijck, M & Kinsella, N 2022, 'Developing a consensus statement for psychosocial support in active surveillance for prostate cancer', BJUI Compass, online, pp. 1-10. Open access
2022	Beckmann, K, Crawley, D, Nelson, WG, Platz, EA, Selvin, E, Van Hemelrijck, M & Rohrmann, S 2022, 'Hormonal patterns in men with prediabetes and diabetes in NHANES III: possible links with prostate cancer', Cancer Causes and Control, vol. 33, no. 3, pp. 429-440. 2 2 1
2022	Beckmann, K, Kearney, BJ, Yeung, D, Hiwase, D, Li, M & Roder, DM 2022, 'Changes in five-year survival for people with acute leukaemia in South Australia, 1980-2016', Medical Journal of Australia, vol. 216, no. 6, pp. 296-302. Open access 1 2 26
2022	Beckmann, K, Santaolalla, A, Sugimoto, M, Carroll, P, Rubio, J, Villers, A, Bjartell, A, Morgan, T, Dasgupta, P, Van Hemelrijck, M & Elhage, O 2022, 'Risk of progression following a negative biopsy in prostate cancer active surveillance', Prostate Cancer and Prostatic Diseases, online, pp. 1-7. Open access
2022	Beckmann, KR, Bangma, CH, Helleman, J, Bjartell, A, Carroll, PR, Morgan, T, Nieboer, D, Santaolalla, A, Trock, BJ, Valdagni, R & Roobol, MJ and 1 consortium 2022, 'Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: an analysis of the G.A.P.3 global consortium database', Prostate, vol. 82, no. 7, pp. 876-879. Open access 1
2022	Bundred, JR, Michael, S, Stuart, B, Cutress, R I, Beckmann, K, Holleczek, B, Dahlstrom, JE, Gath, J, Dodwell, D & Bundred, NJ 2022, 'Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis', BMJ: British Medical Journal, vol. 378, article no. e070346, pp. 1-11. Open access 4
2022	Monroy-Iglesias, MJ, Crescioli, S, Beckmann, K, Le, N, Karagiannis, SN, Van Hemelrijck, M & Santaolalla, A 2022, 'Antibodies as biomarkers for cancer risk: a systematic review', Clinical and Experimental Immunology, vol. 209, no. 1, pp. 46-63. Open access 3 3
2022	Tiruye, T, O'Callaghan, M, Moretti, K, Jay, A, Higgs, B, Santoro, K, Boyle, T, Ettridge, K & Beckmann, K 2022, 'Patient-reported functional outcome measures and treatment choice for prostate cancer', BMC Urology, vol. 22, article no. 1, pp. 1-11. Open access
2021	Beckmann, K, Cahill, D, Brown, C, van Hemelrijck, M & Kinsella, N 2021, 'Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer', Translational Andrology and Urology, vol. 10, no. 6, pp. 2728-2736. Open access 6 6 7
2021	Beckmann, K, Garmo, H, Lissbrant, IF & Stattin, P 2021, 'The value of real-world data in understanding prostate cancer risk and improving clinical care: examples from Swedish registries', Cancers, vol. 13, no. 4, article no. 875, pp. 1-19. Open access 2 1 10
2021	Beckmann, K, Santaolalla, A, Helleman, J, Carroll, P, Ha Chung, B, Shiong Lee, L, Perry, A, Rubio-Briones, J, Sugimoto, M, Trock, B, Valdagni, R, Dasgupta, P, Van Hemelrijck, M & Elhage, O 2021, 'Comparison of characteristics, follow-up and outcomes of active surveillance for prostate cancer according to ethnicity in the GAP3 Global Consortium Database', European Urology Open Science, vol. 34, pp. 47-54. Open access 1 6
2021	Beckmann, K, Selva-Nayagam, S, Olver, I, Miller, C, Buckley, ES, Powell, K, Buranyi-Trevarton, D, Gowda, R, Roder, D & Oehler, MK 2021, 'Carcinosarcomas of the uterus: prognostic factors and impact of adjuvant treatment', Cancer Management and Research, vol. 13, pp. 4633-4645. Open access 3 3 1
2021	Bott, RK, Beckmann, K, Zylstra, J, Wilkinson, MJ, Knight, WR, Baker, CR, Kelly, M, Maisey, N, Waters, J, Van Hemelrijck, M, Smyth, EC, Allum, WH, Lagergren, J, Gossage, JA, Cunningham, D & Davies, AR 2021, 'Adjuvant therapy following neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma in patients with clear resection margins', Acta Oncologica, vol. 60, no. 5, pp. 672-680. 2 2
2021	Kum, F, Beckmann, K, Aya, H, Singh, S, Sandhu, P, Sra, S, Rusere, J, Zisengwe, G, Santaolalla, A, Cathcart, P, Challacombe, B, Brown, C, Popert, R, Dasgupta, P, Van Hemelrijck, M & Elhage, O 2021, 'Presentation, follow-up, and outcomes among African/Afro-Caribbean men on active surveillance for prostate cancer: experiences of a high-volume UK centre', Prostate Cancer and Prostatic Diseases, vol. 24, no. 2, pp. 549-557. 1 1 7
2021	Monroy Iglesias, MJ, Moss, C, Beckmann, K, Hammar, N, Walldius, G, Bosco, C, Van Hemelrijck, M & Santaolalla, A 2021, 'Serum total bilirubin and risk of cancer: a Swedish cohort study and meta‐analysis', Cancers, vol.13, no. 21, article no. 5540, pp.1-13. Open access 3 3 2
2021	Monroy-Iglesias, MJ, Russell, B, Crawley, D, Allen, NE, Travis, RC, Perez-Cornago, A, Van Hemelrijck, M & Beckmann, K 2021, 'Metabolic syndrome biomarkers and prostate cancer risk in the UK Biobank', International Journal of Cancer, vol. 148, no. 4, pp. 825-834. 10 10 1
2021	Shah, S, Beckmann, K, Van Hemelrijck, M, Challacombe, B, Popert, R, Dasgupta, P, Rusere, J, Zisengwe, G, Elhage, O & Santaolalla, A 2021, 'Guy's and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database', BMC Cancer, vol. 21, no. 1, article no. 573, pp. 1-12. Open access 1 1 2
2021	Singh, S, Sandhu, P, Beckmann, K, Santaolalla, A, Dewan, K, Clovis, S, Rusere, J, Zisengwe, G, Challacombe, B, Brown, C, Cathcart, P, Popert, R, Dasgupta, P, Van Hemelrijck, M & Elhage, O 2021, 'Negative first follow‐up prostate biopsy on active surveillance is associated with decreased risk of upgrading, suspicion of progression and converting to active treatment', BJU International, vol. 128, no. 1, pp. 72-78. Open access 1 2 117
2020	Beckmann, K, Garmo, H, Lindahl, B, Holmberg, L, Stattin, P, Adolfsson, J, Cruickshank, JK & Van Hemelrijck, M 2020, 'Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study', Prostate Cancer and Prostatic Diseases, vol. 23, no. 3, pp. 527-533. 6 8 14
2020	Beckmann, K, Garmo, H, Nilsson, P, Lissbrant, IF, Widmark, A & Stattin, P 2020, 'Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998-2016', Acta Oncologica, vol. 59, no. 5, pp. 549-557. Open access 10 11
2020	Bott, R, Beckmann, K, Zylstra, J, Wilkinson, M, Knight, W, Baker, C, Kelly, M, Maisey, N, Qureshi, A, Sevitt, T, Van Hemelrijck, M, Smyth, E, Allum, W, Lagergren, J, Gossage, J, Cunningham, D & Davies, A and 1 consortia 2020, 'Adjuvant therapy following oesophagectomy for adenocarcinoma in patients with a positive resection margin', British Journal of Surgery, vol. 107, no. 13, pp. 1801-1810. Open access 5 6 16
2020	Burdett, N, Hsu, K, Xiong, L, Tapia-Rico, G, Beckmann, K, Karapetis, C & Brown, MP 2020, 'Cancer outcomes in patients requiring immunosuppression in addition to corticosteroids for immune-related adverse events after immune checkpoint inhibitor therapy', Asia Pacific Journal of Clinical Oncology, vol. 16, no. 2, pp. e139-e145. 7 7 2
2020	Morias, S, Buckley, E, Beckmann, K, O'Callaghan, M, Borg, M & Short, M 2020, 'Variation in radiotherapy patterns of care in the radical treatment of South Australian men with non-metastatic prostate cancer between 2005-2015', Radiotherapy and Oncology, vol. 145, pp. 138-145. Open access 1 1 2
2020	Parker, J, Crawley, D, Garmo, H, Lindahl, B, Styrke, J, Adolfsson, J, Lambe, M, Stattin, P, Van Hemelrijck, M & Beckmann, K 2020, 'Use of warfarin or direct oral anticoagulants and risk of prostate cancer in PCBaSe: a nationwide case-control study', Frontiers in Oncology, vol. 10, article no. 571838, pp. 1-8. Open access 4 4 2
2020	Santaolalla, A, Beckmann, K, Kibaru, J, Josephs, D, Van Hemelrijck, M & Irshad, S 2020, 'Association between vitamin D and novel SARS-CoV-2 respiratory dysfunction - a scoping review of current evidence and its implication for COVID-19 pandemic', Frontiers in Physiology, vol. 11, article no. 564387, pp. 1-18. Open access 20 19 68
2019	Ahlberg, MS, Adami, H-O, Beckmann, K, Bertilsson, H, Bratt, O, Cahill, D, Egevad, L, Garmo, H, Holmberg, L, Johansson, E, Rannikko, A, Van Hemelrijck, M, Jäderling, F, Wassberg, C, Åberg, UW & Bill-Axelson, A 2019, 'PCASTt/SPCG-17—a randomised trial of active surveillance in prostate cancer: rationale and design', BMJ Open, vol. 9, no. 8, pp. 1-7. Open access 13 13 6
2019	Beckmann, K, Crawley, D, Nordström, T, Aly, M, Olsson, H, Lantz, A, Binti Abd Jalal, N, Garmo, H, Adolfsson, J, Eklund, M & Van Hemelrijck, M 2019, 'Association between antidiabetic medications and prostate-specific antigen levels and biopsy results', JAMA network open, vol. 2, no. 11, article no. e1914689, pp. 1-12. Open access 14 13 72
2019	Beckmann, K, Garmo, H, Adolfsson, J, Bosco, C, Johansson, E, Robinson, D, Holmberg, L, Stattin, P & Van Hemelrijck, M 2019, 'Androgen deprivation therapies and changes in comorbidity: a comparison of gonadotropin-releasing hormone agonists and antiandrogen monotherapy as primary therapy in men with high-risk prostate cancer', European Urology, vol. 75, no. 4 pp. 676-683. Open access 10 10 19
2019	Beckmann, K, Kinsella, N, Olsson, H, Wallerstedt Lantz, A, Nordstrom, T, Aly, M, Adolfsson, J, Eklund, M & Van Hemelrijck, M 2019, 'Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?', BMC Urology, vol.19, article no. 73, pp. 1-8. Open access 10
2019	Beckmann, K, O'Callaghan, M, Vincent, A, Cohen, P, Borg, M, Roder, D, Evans, S, Millar, J & Moretti, K 2019, 'Extent and predictors of grade upgrading and downgrading in an Australian cohort according to the new prostate cancer grade groupings', Asian Journal of Urology, vol. 6, no. 4, pp. 321-329. Open access 5 5 1
2019	Beckmann, K, Russell, B, Josephs, D, Garmo, H, Haggstrom, C, Holmberg, L, Stattin, P, Van Hemelrijck, M & Adolfsson, J 2019, 'Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: A population-based case-control study', BMC Cancer, vol. 19, no. 1, article no. 612, pp 1-9. Open access 4 6 1
2019	Kinsella, N, Beckmann, K, Cahill, D, Elhage, O, Popert, R, Cathcart, P, Challacombe, B, Brown, C & Van Hemelrijck, M 2019, 'A single educational seminar increases confidence and decreases dropout from active surveillance by 5 years a diagnosis of prostate cancer', European Urology Oncology, vol. 2, no. 4, pp. 464-470. Open access 5 5 25
2019	Tabár, L, Dean, PB, Chen, THH, Yen, AMF, Chen, SLS, Fann, JCY, Chiu, SYH, Ku, MMS, Wu, WYY, Hsu, CY, Chen, YC, Beckmann, K, Smith, RA & Duffy, SW 2019, 'The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening', Cancer, vol. 125, no. 4, pp. 515-523. Open access 113 107 841
2019	Wu, WY-Y, Tabar, L, Tot, T, Fann, C-Y, Yen, AM-F, Chen, SL-S, Chiu, SY-H, Ku, MM-S, Hsu, C-Y, Beckmann, KR, Smith, RA, Duffy, SW & Chen, H-H 2019, 'Imaging Biomarkers as Predictors for Breast Cancer Death', Journal of Oncology, vol. 2019, article no. 2087983, pp. 1-13. Open access 8 8
2018	Beckmann, K, O'Callaghan, M, Vincent, A, Roder, D, Millar, J, Evans, S, McNeil, J & Moretti, K 2018, 'Australian validation of the Cancer of the Prostate Risk Assessment Post-Surgical score to predict biochemical recurrence after radical prostatectomy', ANZ Journal of Surgery, vol. 88 x 1445-1433, no. 3, pp. E183-E188. 2 2 1
2018	Hsieh, AHC, Tahkar, H, Koczwara, B, Kichenadasse, G, Beckmann, K, Karapetis, C & Sukumaran, S 2018, 'Pre-treatment serum lactate dehydrogenase as a biomarker in small cell lung cancer', Asia Pacific Journal of Clinical Oncology, vol. 14, no. 2, pp. e64-e70. 7 7
2018	Lu, TC, Moretti, K, Beckmann, K, Cohen, P & O'Callaghan, M 2018, 'ISUP Group 4: a homogenous group of prostate cancers?', Pathology and Oncology Research, vol. 24, no. 2, pp. 921-925. 6 7
2018	Russell, B, Garmo, H, Beckmann, K, Stettin, P, Adolfsson, J & Van Hemelrijck, M 2018, 'A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0', PLoS One, vol. 13, no. 4, article no. e0195690, pp. 1-10. Open access 5 4
2018	Tabar, L, Chen, THH, Yen, AMF, Chen, SLS, Fann, JCY, Chiu, SYH, Ku, MM, Wu, WYY, Hsu, CY, Chen, YY, Beckmann, K, Smith, RA & Duffy, SW 2018, 'Effect of mammography screening on mortality by histological grade', Cancer Epidemiology, Biomarkers and Prevention, vol. 27, no. 2, pp. 154-157. Open access 24 21 20
2017	Beckmann, K, Moore, J, Wattchow, D, Young, G & Roder, D 2017, 'Short-term outcomes after surgical resection for colorectal cancer in South Australia', Journal of Evaluation in Clinical Practice, vol. 23, no. 2, pp. 316-324. 15 14
2017	Beckmann, K, Vincent, A, O'Callaghan, M, Cohen, P, Chang, S, Borg, M, Evans, S, Roder, D & Moretti, K 2017, 'Oncological outcomes in an Australian cohort according to the new prostate cancer grading groupings', BMC Cancer, vol. 17, no. 1, article no. 537, pp. 1-10. Open access 2 2 1
2017	Beckmann, KR, O'Callaghan, ME, Ruseckaite, R, Kinnear, N, Miller, C, Evans, S, Roder, DM & Moretti, K 2017, 'Prostate cancer outcomes for men who present with symptoms at diagnosis', BJU International, vol. 119, no. 6, pp. 862-871. 6 5
2017	Buckley, E, Farshid, G, Gill, G, Kollias, J, Koczwara, B, Karapetis, C, Adams, J, Joshi, R, Keefe, D, Niyonsenga, T, Powell, K, Fusco, K, Eckert, M, Beckmann, K & Roder, D 2017, 'Assessing impact of organised breast screening across small residential areas: development and internal validation of a prediction model', European Journal of Cancer Care, vol. 26, no. 4, article no. e12673, pp. 1-8. 2
2017	Campbell, JM, O'Callaghan, ME, Raymond, E, Vincent, AD, Beckmann, KR, Roder, D, Evans, S, McNeil, J, Millar, J, Zalcberg, J, Borg, M & Moretti, KL 2017, 'Tools for predicting clinical and patient-reported outcomes in prostate cancer patients undergoing androgen deprivation therapy: a systematic review of prognostic accuracy and validity', Clinical Genitourinary Cancer, vol. 15, no. 6, pp. 629-634. 5 3 2
2017	Campbell, JM, Raymond, E, O'Callaghan, ME, Vincent, AD, Beckmann, KR, Roder, D, Evans, S, McNeil, J, Millar, J, Zalcberg, J, Borg, M & Moretti, KL 2017, 'Optimum tools for predicting clinical outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity', Clinical Genitourinary Cancer, vol. 15, no. 5, pp. e827-e834. 11 12 1
2017	O'Callaghan, M, Raymond, E, Campbell, J, Vincent, A, Beckmann, K, Roder, D, Evans, S, McNeil, J, Millar, J, Zalcberg, J, Borg, M & Moretti, K 2017, 'Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validity', Prostate Cancer and Prostatic Diseases, vol. 20, no. 4, pp. 378-388. 14 13 2
2017	O'Callaghan, ME, Raymond, E, Campbell, JM, Vincent, AD, Beckmann, K, Roder, D, Evans, S, McNeil, J, Millar, J, Zalcberg, J, Borg, M & Moretti, K 2017, 'Patient-reported outcomes after radiation therapy in men with prostate cancer: a systematic review of prognostic tool accuracy and validity', International Journal of Radiation Oncology Biology Physics, vol. 98, no. 2, pp. 318-337. 10 9 2
2017	Raymond, E, O'Callaghan, ME, Campbell, J, Vincent, AD, Beckmann, KR, Roder, DM, Evans, S, McNeil, J, Millar, J, Zalcberg, J, Borg, M & Moretti, K 2017, 'An appraisal of analytical tools used in predicting clinical outcomes following radiation therapy treatment of men with prostate cancer: a systematic review', Radiation Oncology, vol. 12, article no. 56, pp. 1-20. Open access 12 10
2017	Roder, D, Farshid, G, Gill, G, Kollias, J, Koczwara, B, Karapetis, C, Adams, J, Joshi, R, Keefe, D, Powell, K, Fusco, K, Eckert, M, Buckley, E & Beckmann, K 2017, 'Breast cancer screening: opportunistic use of registry and linked screening data for local evaluation', Journal of Evaluation in Clinical Practice, vol. 23, no. 3, pp. 508-516. Open access 2 2 1
2017	Roder, D, Farshid, G, Kollias, J, Koczwara, B, Karapetis, C, Adams, J, Joshi, R, Keefe, D, Miller, C, Powell, K, Fusco, K, Eckert, M, Buckley, E, Beckmann, K & Price, T 2017, 'Female breast cancer management and survival: The experience of major public hospitals in South Australia over 3 decades-trends by age and in the elderly', Journal of Evaluation in Clinical Practice, vol. 23, no. 6, pp. 1433-1443. 4 5
2017	Tabar, L, Chen, THH, Hsu, CY, Wu, WYY, Yen, AMF, Chen, SLS, Chiu, SYH, Fann, JCY, Beckmann, KR, Smith, RA & Duffy, SW 2017, 'Evaluation issues in the Swedish two-county trial of breast cancer screening: An historical review', Journal of Medical Screening, vol. 24, no. 1, pp. 27-33. Open access 10 4 1
2016	Beckmann, KR, Bennett, A, Young, GP, Cole, SR, Joshi, R, Adams, J, Singhal, N, Karapetis, CS, Wattchow, D & Roder, D 2016, 'Sociodemographic disparities in survival from colorectal cancer in South Australia: a population-wide data linkage study', BMC Health Services Research, vol. 16, no. 24, pp. 1-14. Open access 46 42 2
2016	Ruseckaite, R, Beckmann, K, O'Callaghan, M, Roder, D, Moretti, K, Millar, J & Evans, S 2016, 'A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease', BMC Cancer, vol. 16, article no. 607, pp. 1-11. Open access 17 16 11
2016	Ruseckaite, R, Beckmann, K, O'Callaghan, M, Roder, DM, Moretti, K, Zalcberg, J, Millar, J & Evans, S 2016, 'Development of South Australian-Victorian prostate cancer health outcomes research dataset', BMC Research Notes, vol. 9, no. 37 pp. 1 - 11. Open access 4 1
2015	Beckmann, K, Duffy, SW, Lynch, J, Hiller, J, Farshid, G & Roder, D 2015, 'Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects', Journal of Medical Screening, vol. 22, no. 3, pp. 127-135. Open access 19 18 23
2014	Beckmann, KR, Bennett, A, Young, GP & Roder, DM 2014, 'Treatment patterns among colorectal cancer patients in South Australia: a demonstration of the utility of population-based data linkage', Journal of Evaluation in Clinical Practice, vol. 20, no. 4, pp. 467-477. 29 28 1
2014	Beckmann, KR, Roder, DM, Hiller, JE, Farshid, G & Lynch, JW 2014, 'Influence of mammographic screening on breast cancer incidence trends in South Australia', Asian Pacific Journal of Cancer Prevention, vol. 15, no. 7, pp. 3105-3112. Open access 7 2
2013	Beckmann, K, Roder, D, Hiller, J, Farshid, G & Lynch, J 2013, 'Do breast cancer risk factors differ among those who do and do not undertake mammography screening?', Journal of Medical Screening, vol. 20 no. 4, pp. 208-219. Open access 12 13
2013	Beckmann, KR, Farshid, G, Roder, DM, Hiller, JE & Lynch, JW 2013, 'Impact of hormone replacement therapy use on mammographic screening outcomes', Cancer Causes and Control, vol. 24, no. 7, pp. 1417-1426. 5 5 5
2013	Behm, EC, Beckmann, KR, Dahlstrom, JE, Zhang, Y, Cho, C, Stuart-Harris, R, Craft, P, Rezo, A & Buckingham, JM 2013, 'Surgical margins and risk of locoregional recurrence in invasive breast cancer: an analysis of 10-year data from the breast cancer treatment quality assurance project', BREAST, vol. 22, no. 5, pp. 839-844. 29 26 5
2012	Dobbinson, S, Wakefield, M, Hill, D, Girgis, A, Aitken, JF, Beckmann, K, Reeder, A I, Herd, N, Spittal, MJ, Fairthorne, A & Bowles, K-A 2012, 'Children's sun exposure and sun protection: prevalence in Australia and related parental factors', Journal of the American Academy of Dermatology, vol. 66, no. 6, pp. 938-947. 34 27 7
2011	Beckmann, K, Buckingham, J, Craft, P, Dahlstrom, J, Zhang, Y, Roder, D & Stuart-Harris, R 2011, 'Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort', BREAST, vol. 20, no. 2, pp. 158-164. Open access 52 51
2010	Craft, PS, Buckingham, JM, Dahlstrom, JE, Beckmann, KR, Zhang, Y, Stuart-Harris, R, Jacob, G, Roder, D & Tait, N 2010, 'Variation in the management of early breast cancer in rural and metropolitan centres: Implications for the organisation of rural cancer services', BREAST, vol. 19, no. 5, pp. 396-401. Open access 40 37
2009	Beckmann, K, Pinnock, CB, Tamblyn, DJ, Kopsaftis, T, Stapleton, AM & Roder, DM 2009, 'Clinical and socio-demographic profile of an Australian multi-institutional prostate cancer cohort', Asia Pacific Journal of Clinical Oncology, vol. 5, no. 4, pp. 247-256. 11 10
2009	Beckmann, KR, Olver, IN, Young, GP, Roder, DM, Foreman, LM & Wilson, B 2009, 'Patient and carer perceptions of cancer care in South Australia', Australian Health Review, vol. 33, no. 4, pp. 645-655. Open access 2 2
2008	Dobbinson, SJ, Wakefield, M, Hill, DJ, Girgis, A, Aitken, J, Beckmann, KR, Reeder, AI, Herd, N, Fairthorne, A & Bowles, KA 2008, 'Prevalence and determinants of Australian adolescents' and adults' weekend sun protection and sunburn, summer 2003-2004', Journal of the American Academy of Dermatology, vol. 59, no. 4, pp. 602-614. 113 101
2008	Jones, S, Beckmann, KR & Rayner, JR 2008, 'Australian primary schools' sun protection policy and practice: Evaluating the impact of the National Sunsmart Schools Program', Health Promotion Journal of Australia, vol. 19, no. 2, pp. 86-90. 47 14
2008	Jones, S, Rayner, JR & Beckmann, KR 2008, 'Solaria compliance with the Australia/New Zealand Standard in Adelaide', Health Promotion Journal of Australia, vol. 19, no. 3, pp. 222-225. 2 2
2008	Luke, C, Koczwara, B, Karapetis, CS, Pittman, K, Price, TJ, Kotasek, D, Beckmann, KR, Brown, MP & Roder, DM 2008, 'Exploring the epidemiological characteristics of cancers of unknown primary site in an Australian population: Implications for research and clinical care', Australian and New Zealand Journal of Public Health, vol. 32, no. 4, pp. 383-389. 29 31
2008	Roder, DM, Houssami, N, Farshid, G, Gill, G, Luke, C, Downey, P, Beckmann, KR, Losifidis, P, Grieve, L & Williamson, L 2008, 'Population screening and intensity of screening are associated with reduced breast cancer mortality: Evidence of efficacy of mammography screening in Australia ', Breast Cancer Research and Treatment, vol. 108, no. 3, pp. 409-416. 105 100
2008	Shahid, S, Beckmann, KR & Thompson, S 2008, 'Supporting cancer control for indigenous Australians: Initiatives and challenges for cancer councils', Australian Health Review, vol. 32, no. 1, pp. 56-65. 14 7

External engagement & recognition

Collaborations

Highlights

Kerri was the primary organiser of the Prostate Cancer Living Well After Treatment public forum in Adelaide in November 2016, which was attended by 200 men with prostate cancer, family members and friends.

Kerri has been engaged in the following committes:

Deputy Chair Prostate Cancer Clinical Outcomes Collaborative Research Committee (2014-2017)
Member Prostate Cancer Clinical Outcomes Collaborative Steering Committee (2007-2017)
Member Prostate Cancer Clinical Outcomes Collaborative Research Committee (2007-2014)
Deputy member SA NT DataLink Steering Committee (2009-2011)
Deputy member SA Department of Health Ethics Committee (2008-2011)
Member Cancer Council SA Ethics Committee (2008-2011)

External engagement & recognition

Collaborations

Organisation	Country
ACT and SE NSW Breast Cancer Treatment Group	AUSTRALIA
ACT Health	AUSTRALIA
Adelaide Radiotherapy Centre	AUSTRALIA
Akademiska Sjukhuset	SWEDEN
Alfred Health	AUSTRALIA
American Cancer Society	UNITED STATES
Austin Hospital	AUSTRALIA
Australian Catholic University	AUSTRALIA
Australian National University	AUSTRALIA
BreastScreen SA	AUSTRALIA
Calvary Hospital	UNITED STATES
Canberra Hospital	AUSTRALIA
Cancer Council Australia	AUSTRALIA
Cancer Council of South Australia	AUSTRALIA
Cancer Council Queensland	AUSTRALIA
Cancer Council Victoria	AUSTRALIA
Chandlers Hill Surgery	AUSTRALIA
Chang Gung University	TAIWAN
Country Health SA	AUSTRALIA
Curtin University	AUSTRALIA
Debre Markos University	ETHIOPIA
Erasmus MC	NETHERLANDS
Erasmus MC Cancer Institute	NETHERLANDS
Falun Hospital	SWEDEN
Flinders Medical Centre	AUSTRALIA
Flinders University	AUSTRALIA
Fondazione IRCCS Istituto Nazionale dei Tumori	ITALY
Fundacin Instituto Valenciano de Oncologa	SPAIN
Gangnam Severance Hospital	KOREA, REPUBLIC OF (SOUTH)
Genesis Care	AUSTRALIA
German Cancer Research Center	GERMANY
Guy’s Hospital	UNITED KINGDOM
Guy's and St Thomas' NHS Foundation Trust	UNITED KINGDOM
Guys Hospital	UNITED KINGDOM
Guy's Hospital	UNITED KINGDOM
Helsinki University Hospital	FINLAND
Independent Cancer Patients' Voice	UNITED KINGDOM
Instituto Valenciano de Oncologia	SPAIN
Johns Hopkins Bloomsburg School of Public Health	UNITED STATES
Johns Hopkins Medicine	UNITED STATES
Johns Hopkins University	UNITED STATES
Kagawa University	JAPAN
Kainan University	TAIWAN
Karalinska Institute	SWEDEN
Karalinska University	SWEDEN
Karalinska University Hospital	SWEDEN
Karolinska Institute	SWEDEN
Karolinska Institute, Sweden	SWEDEN
Karolinska University Hospital	SWEDEN
King's College London	UNITED KINGDOM
KINGS COLLEGE, Vic	AUSTRALIA
King's Hospital London	UNITED KINGDOM
Lille University Hospital Center	FRANCE
Lund University	SWEDEN
Lyell McEwin Hospital	AUSTRALIA
Maidstone Hospital	UNITED KINGDOM
Manchester University	UNITED STATES
Monash University	AUSTRALIA
National Taiwan University	TAIWAN
NHS Foundation Trust	UNITED KINGDOM
Northern Adelaide Local Health Network	AUSTRALIA
Norwegian University of Science and Technology	NORWAY
Prepatriation Hospital	AUSTRALIA
Private Individual	AUSTRALIA
Queen Elizabeth Hospital	AUSTRALIA
Queen Mary University of London	UNITED KINGDOM
Regional Cancer Centre, Uppsala	SWEDEN
Repatriation General Hospital	AUSTRALIA
Royal Adelaide Hospital	AUSTRALIA
Royal Marsden Hospital	UNITED KINGDOM
Ryhov Hospital	SWEDEN
SA Health	AUSTRALIA
SA Pathology	AUSTRALIA
Sahlgrenska University	SWEDEN
Sidney Kimmel Comprehensive Cancer Center	UNITED STATES
Singapore General Hospital	SINGAPORE
Skane University Hospital	SWEDEN
Skne University Hospital	SWEDEN
South Australian Health and Medical Research Institute (SAHMRI)	AUSTRALIA
South Australian Prostate Cancer Clinical Outcomes Collaborative (SA-PCCOC)	AUSTRALIA
St Thomas Hospital	UNITED KINGDOM
St Thomas' Hospital	UNITED KINGDOM
Swinburne University of Technology	AUSTRALIA
Taipei City Hospital	TAIWAN
Taipei Medical University	TAIWAN
The Alfred Hospital	AUSTRALIA
The Cancer Council Victoria	AUSTRALIA
The Trustee for the Movember Foundation	AUSTRALIA
UCSF Helen Diller Family Comprehensive Cancer Center	UNITED STATES
Umeå Universitet	SWEDEN
Umeå University	SWEDEN
Universita Degli Studi di Milano	ITALY
University College Dublin	IRELAND
University of Adelaide	AUSTRALIA
University of California San Francisco	UNITED STATES
University of Gothenburg	SWEDEN
University of Leeds	UNITED KINGDOM
University of Michigan	UNITED STATES
University of Newcastle	AUSTRALIA
University of Otago	NEW ZEALAND
University of Otago Dunedin School of Medicine	NEW ZEALAND
University of Oxford	UNITED KINGDOM
University of South Australia	AUSTRALIA
University of Southampton	UNITED KINGDOM
University of Sydney	AUSTRALIA
University of Tasmania	AUSTRALIA
University of Turku	FINLAND
University of Uppsala	SWEDEN
University of Western Australia	AUSTRALIA
University of Wollongong	AUSTRALIA
University of Zurich	SWITZERLAND
Uppsala University	SWEDEN
Uppsala University Hospital	SWEDEN

External engagement & recognition

Engagement/recognition	Year
Member Australasian Epidemiological Association (AEA)	2018
Academic Advisor NSW Cancer Institute	2017
Member Australasian Epidemiological Association (AEA)	2017
Member, Steering Committee South Australian Prostate Cancer Clinical Outcomes Collaborative	2017
Academic Advisor NSW Cancer Institute	2016
Best Poster Award World Prostate Cancer Congress	2016
Member, Steering Committee South Australian Prostate Cancer Clinical Outcomes Collaborative	2016
Public Forum Convenor South Australian Prostate Cancer Clinical Outcomes Collaborative	2016
Deputy Chair, Research Committee South Australian Prostate Cancer Clinical Outcomes Collaborative	2015
Early Career Researcher Networking Award Taiwanese Cancer Screening Research Group	2015
Member, Steering Committee South Australian Prostate Cancer Clinical Outcomes Collaborative	2015
Deputy Chair, Research Committee South Australian Prostate Cancer Clinical Outcomes Collaborative	2014
Member, Steering Committee South Australian Prostate Cancer Clinical Outcomes Collaborative	2014
Deputy Chair, Research Committee South Australian Prostate Cancer Clinical Outcomes Collaborative	2013
Member, Steering Committee South Australian Prostate Cancer Clinical Outcomes Collaborative	2013
Member, Research Committee South Australian Prostate Cancer Clinical Outcomes Collaborative	2012
Member, Steering Committee South Australian Prostate Cancer Clinical Outcomes Collaborative	2012
Deputy Member, Ethics Committee Department of Health, Government of South Australia	2011
Deputy Member, Steering Committee DataLink SA NT	2011
Member, Ethics Committee Cancer Council	2011
Member, Research Committee South Australian Prostate Cancer Clinical Outcomes Collaborative	2011
Member, Steering Committee South Australian Prostate Cancer Clinical Outcomes Collaborative	2011
Deputy Member, Ethics Committee Department of Health, Government of South Australia	2010
Deputy Member, Steering Committee DataLink SA NT	2010
Member, Ethics Committee Cancer Council	2010
Member, Research Committee South Australian Prostate Cancer Clinical Outcomes Collaborative	2010
Member, Steering Committee South Australian Prostate Cancer Clinical Outcomes Collaborative	2010
Deputy Member, Ethics Committee Department of Health, Government of South Australia	2009
Deputy Member, Steering Committee DataLink SA NT	2009
Member, Ethics Committee Cancer Council	2009
Member, Research Committee South Australian Prostate Cancer Clinical Outcomes Collaborative	2009
Member, Steering Committee South Australian Prostate Cancer Clinical Outcomes Collaborative	2009
Deputy Member, Ethics Committee Department of Health, Government of South Australia	2008
Member, Ethics Committee Cancer Council	2008
Member, Research Committee South Australian Prostate Cancer Clinical Outcomes Collaborative	2008
Member, Steering Committee South Australian Prostate Cancer Clinical Outcomes Collaborative	2008

Teaching & student supervision

Highlights

Kerri has supervised and mentored bachelors, honours and masters students in cancer and clinical epidemiology research projects. She has delivered lectures on epidemiological study designs within undergraduate and master level courses.

Teaching & student supervision

Research degree supervision

Supervisions from 2010 shown

Thesis title	Student status
Step it up a population-based investigation of podiatry service use following neurotoxic chemotherapy	Current

more less

Dr Kerri Beckmann

About me

About me

UniSA Allied Health & Human Performance

About me

Professional Associations

Experience

Qualifications

Work history

Research

Highlights

Projects

Outputs

Highlights

Journal Articles

Current research & highlights

External engagement & recognition

Collaborations

Highlights

Collaborations

External engagement & recognition

Member

Academic Advisor

Member

Member, Steering Committee

Academic Advisor

Best Poster Award

Member, Steering Committee

Public Forum Convenor

Deputy Chair, Research Committee

Early Career Researcher Networking Award

Member, Steering Committee

Deputy Chair, Research Committee

Member, Steering Committee

Deputy Chair, Research Committee

Member, Steering Committee

Member, Research Committee

Member, Steering Committee

Deputy Member, Ethics Committee

Deputy Member, Steering Committee

Member, Ethics Committee

Member, Research Committee

Member, Steering Committee

Deputy Member, Ethics Committee

Deputy Member, Steering Committee

Member, Ethics Committee

Member, Research Committee

Member, Steering Committee

Deputy Member, Ethics Committee

Deputy Member, Steering Committee

Member, Ethics Committee

Member, Research Committee

Member, Steering Committee

Deputy Member, Ethics Committee

Member, Ethics Committee

Member, Research Committee

Member, Steering Committee

Teaching & student supervision

Highlights

Courses and programs

Research degree supervision

Gallery